Boston Scientific’s platinum chromium coronary stent with enhanced delivery system is now available in Europe and other international countries. The company plans to begin marketing the product in select European and other CE Mark countries immediately and will expand to a full market launch in the second quarter.
Boston Scientific Corporation announces the creation of its Asia-Pacific regional organization that includes Australia, New Zealand, China, Hong Kong, India, Japan, South Korea, South East Asia, Taiwan and Turkey. The company believes this pan-Asia business model will help drive growth by leveraging best practices in the region, accessing the strong pool of local talent, and collaborating with healthcare professionals and regulatory agencies throughout the region.
http://bostonscientific.mediaroom.com/index.php?s=24889&item=117746
CEO Hank Kucheman is predicting strong profit growth for Boston Scientific in the next few years as a result of cost-cutting and new products reaching hospitals and doctor’s offices. The company maintains three facilities in Ireland: in Clonmel, Cork and Galway.
http://www.qmed.com/news/boston-scientific-chief-sees-turnaround-horizon
To accommodate our continuing expansion, the company has relocated its corporate headquarters to a new, larger facility in Cork.
“With our rapid growth to more than double our workforce since last May, we needed a larger office to house and meet the needs of additional corporate employees and consultants we hired, and plan to continue hiring,” says General Manager Linda Mellerick. “Not only is our new facility larger, it is more centrally located for both our customers and employees.”
The company continues to expand its technical team and is continually recruiting new engineers and graduates for projects in Ireland and internationally.
GxP System’s new office is located in a high-tech business facility located at The Atrium, Blackpool, Cork. Phone and fax numbers have been changed to +353 21 4215 050 and +353 21 4215 051, respectively.
US pharmaceutical company Allergan has announced a major expansion of its botox facility in Westport, Co Mayo, with the creation of 200 new jobs. In its Westport facility, Allergan manufactures and develops both medical devices and pharmaceutical products.
Today we announce strategic organizational changes to support the projected growth of the company. Tactical changes in both the management team and board of directors will facilitate expansion, both globally and in Ireland:
